A clinical trial to evaluate the effect of Shatavari ghrita on fetal outcome w.s.r. to birth weight
Phase 2
- Registration Number
- CTRI/2020/02/023448
- Lead Sponsor
- All India Institute Of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Primi and second gravida with gestational age 12 to 14 weeks;able and willing to participate and provide signed informed consent
Exclusion Criteria
Severe anaemia Hb <7 gm/dl; pregnancy complicated by placenta praevia, coexisting fibroid, any malignancy,twins; pregnancy complicated with diseases such as hypo or hyperthyroidism, cardiovascular diseases, diabetes.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate the effect of oral administration of Shatavari ghrita during pregnancy on fetal outcome w.s.r. to birth weightTimepoint: Baby fetal weight by USG; Birth weight will be noted at the time of delivery and on 10th after delivery; APGAR score
- Secondary Outcome Measures
Name Time Method Evaluate the effect of oral administration of Shatavari ghrita in garbhini i.e. to minimize the complications of pregnancyTimepoint: Every 15th day in 4th to 6th month;every 8th day in 7th to 9th month; Gestational age at the time of labour; Mode of delivery; Duration of labour